Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma
Xi-Ya Li, Jichuan Wu, Ping Liu, et al.
Leukemia (2022) Vol. 37, Iss. 1, pp. 164-177
Open Access | Times Cited: 19

Showing 19 citing articles:

Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options
Hongli Gao, Zhuo Xi, Jingwei Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Discovery and Optimization of a Series of Novel Morpholine-Containing USP1 Inhibitors
Junjie Zhang, Benjin Liu, Ruiyi Ren, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
USP1 promotes pancreatic cancer progression and autophagy by deubiquitinating ATG14
Leilei Li, Zhili Fan, Mengfei Liu, et al.
Journal of Biological Chemistry (2025), pp. 108190-108190
Open Access
The other side of the coin: protein deubiquitination by Ubiquitin-Specific Protease 1 in cancer progression and therapy
Xinlan Hu, Yan Wu, Mengmeng Yao, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 3, pp. 329-345
Closed Access
Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects
Mohamad Bakkar, Sara I. Khalil, Komal Bhayekar, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 240-240
Open Access
LncRNA OLMALINC promotes osteosarcoma progression through USP1-mediated autophagy suppression
Jianping Li, Bo Yu, Zhaowen Xue, et al.
Human Cell (2025) Vol. 38, Iss. 3
Closed Access
Targeting MYC-driven lymphoma: lessons learned and future directions
Sandra Martínez-Martín, Marie‐Eve Beaulieu, Laura Soucek
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 205-222
Open Access | Times Cited: 8
Spotlights on ubiquitin-specific protease 12 (USP12) in diseases: from multifaceted roles to pathophysiological mechanisms
Kaiyi Niu, Yanlong Shi, Qingpeng Lv, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
ACAT1 promotes proliferation and metastasis of bladder cancer via AKT/GSK3β/c-Myc signaling pathway
Tingjun Wang, Gang Wang, Danni Shan, et al.
Journal of Cancer (2024) Vol. 15, Iss. 11, pp. 3297-3312
Open Access | Times Cited: 2
The ubiquitin-proteasome system in the tumor immune microenvironment: a key force in combination therapy
Yongmei Wang, Saisai Li, Wenqin Wang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Therapeutic Targeting of the GLS1-c-Myc Positive Feedback Loop Suppresses Glutaminolysis and Inhibits Progression of Head and Neck Cancer
Jianqiang Yang, Fanghui Chen, Liwei Lang, et al.
Cancer Research (2024) Vol. 84, Iss. 19, pp. 3223-3234
Closed Access | Times Cited: 1
Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression by Stabilizing C-myc
Xia Zhang, Peng Peng, Liwei Bao, et al.
(2024)
Open Access | Times Cited: 1
USP19 exerts a tumor‐promoting role in diffuse large B cell lymphoma through stabilizing PARK7
Y L Li, Xiyang Liu, Yulai Li, et al.
FEBS Journal (2024)
Closed Access | Times Cited: 1
Prognostic and Immune Landscape Analysis of Ubiquitination-related Genes in Hepatocellular Carcinoma: Based on Bulk and Single-cell RNA Sequencing Data
Zibo Yuan, Qingwei Zhu, Qingsong Wu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 9, pp. 2580-2600
Open Access
Characterizing the Cell-Free Transcriptome in a Humanized Diffuse Large B-Cell Lymphoma Patient-Derived Tumor Xenograft Model for RNA-Based Liquid Biopsy in a Preclinical Setting
Philippe Decruyenaere, Willem Daneels, Annelien Morlion, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9982-9982
Open Access
Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression by Stabilizing c-MYC
Xia Zhang, Peng Peng, Liwei Bao, et al.
Cells (2024) Vol. 13, Iss. 21, pp. 1798-1798
Open Access
Pharmacokinetic Positron Emission Tomography Imaging of an Optimized CD38-Targeted 68Ga-Labeled Peptide in Multiple Myeloma: A Pilot Study
Qi Yang, Lele Song, Zhao Chen, et al.
Bioconjugate Chemistry (2024)
Closed Access
Ubiquitin-specific peptidases in lymphoma: a path to novel therapeutics
Maryam Samareh Salavatipour, Shirin Tavakoli, Aram Halimi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Protein ubiquitination in ovarian cancer immunotherapy: The progress and therapeutic strategy
Huiling Guo, Jianwei Wei, Yuyan Zhang, et al.
Genes & Diseases (2023) Vol. 11, Iss. 6, pp. 101158-101158
Open Access | Times Cited: 1
Page 1

Scroll to top